Understanding the genetic causes of ADHD in families
Official title: Advancing Understanding of Genomic Mechanisms for Primary ADHD in Families
Funded at Boston Children's Hospital · NIH-11145234 · Data updated 2026-11-12
This study is looking at the genetic factors that might cause ADHD in kids aged 0-11, and it’s for families with children who have ADHD to help us learn more about how this condition runs in families.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | August 1, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $755,902 |
| NIH project number | 5R01MH137118-02 |
| Project ID | NIH-11145234 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children aged 0-11 years diagnosed with primary ADHD and their family members.
✕Less likely to help
Patients with ADHD who also have significant comorbid conditions, such as severe intellectual disability or autism, may not benefit from this research.
What this research studies
This research investigates the genetic mechanisms behind primary ADHD, particularly in children aged 0-11 years. It aims to create a comprehensive family-based repository that includes children with ADHD and their family members, using standardized diagnostic criteria to ensure accurate ADHD diagnoses. By analyzing genomic data, the research seeks to identify rare genetic variants that may contribute to ADHD, enhancing our understanding of this condition and its familial patterns.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and targeted treatments for children with primary ADHD.
How similar studies have gone: Previous research has shown promise in understanding genetic factors in ADHD, but this approach aims to provide a more focused and comprehensive analysis of primary ADHD, making it a novel endeavor.
Where this research is happening
-
Boston Children's Hospital
Boston, United States Active
Researchers
- Principal investigator: Doan, Ryan Neil — Boston Children's Hospital
- Study coordinator: Doan, Ryan Neil
Related research
Other NIH-funded projects on the same topics.
-
Biobehavioral validation of the ADHD emotion dysregulation phenotype
A study with children who have ADHD is testing how emotion regulation and thinking skills fit together to better understand why ADHD shows up differently in kids.
-
Hybrid school clinician training and ADHD/ODD program for Mexico
A school-based program to train clinicians and deliver a digital ADHD/ODD intervention in Mexican schools, helping children in real-world settings.
-
Hybrid school clinician training and ADHD/ODD intervention for schools in Mexico
A program that trains school clinicians and provides a digitally enhanced ADHD/ODD intervention to elementary-age students in Mexican schools to improve outcomes.
-
Nonstimulant-First vs Stimulant-First ADHD Treatment in Adults
This trial tests whether starting ADHD treatment with a nonstimulant medication works as well as starting with a stimulant for adults with ADHD.
-
Treating Adult ADHD Around the Clock: A Sleep-Focused Treatment Trial
A Duke-led study tests a care plan that uses a sleep-focused program, with or without CBT-based ADHD therapy, to help adults with ADHD sleep better and function more during the day.
-
Motivational Interviewing–Enhanced CBT for Adults with ADHD
A new program tests whether adding Motivational Interviewing to CBT helps adults with ADHD engage in treatment and improve daily functioning.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.